Daniel Andritschke

1PUBLICATIONS
5CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Feb 07, 2023
Cost-effectiveness of pembrolizumab as an adjuvant treatment for patients with resected stage IIB or IIC melanoma in Switzerland.

Andrea Favre-Bulle, Goran Bencina, Shujing Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Andrea Favre-Bulle

1 joint publications

Goran Bencina

1 joint publications

Shujing Zhang

1 joint publications

Ruixuan Jiang